Association between neutrophil to lymphocyte ratio and pulmonary arterial hypertension

Turk Kardiyoloji Dernegi Arsivi

Volumn 41, Issue 7, 2013, Pages 604-609

  Yildiz, Abdulkadir ^a   Kaya, Hasan ^a   Ertaş, Faruk ^a   Oylumlu, Mustafa ^a   Bilik, Mehmet Zihni ^a   Yüksel, Murat ^a   Polat, Nihat ^a   Akil, Mehmet Ata ^a   Atilgan, Zuhal ^a   Ülgen, Mehmet Siddik ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Biological markers; Heart failure; Hypertension; Infammation; N L orani; Pulmonary; Pulmonary artery

Indexed keywords

ADULT; ARTICLE; BLOOD CELL COUNT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; LYMPHOCYTE; MALE; MULTIVARIATE ANALYSIS; NEUTROPHIL; PREDICTIVE VALUE; PULMONARY HYPERTENSION; SENSITIVITY AND SPECIFICITY; BLOOD; LEUKOCYTE COUNT; MIDDLE AGED; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC;

FEMALE; HUMANS; HYPERTENSION, PULMONARY; LEUKOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; ROC CURVE;

EID: 84891881030     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: 10.5543/tkda.2013.93385     Document Type: Article

References (24)

1. Tuder RM, Abman SH, Braun T, Capron F., Stevens T, Thistle-thwaite PA, et al Development and pathology of pulmonary hypertension. J Am Coll Cardiol 2009;54:3-9.
2. Schermuly RT, Ghofrani HA, Wilkins M.R., Grimminger F. Mechanisms of disease: pulmonary arterial hypertension. Nat Rev Cardiol 2011;8:443-55.
3. Gurm HS, Bhatt DL, Lincoff A.M., Tcheng JE, Kereiakes DJ, Kleiman NS, et al Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials. Heart 2003;89:1200-4.
4. Horne BD, Anderson JL, John J.M., Weaver A., Bair TL, Jensen KR, et al Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005;45:1638-43.
5. Kaya H, Ertas F, Islamoglu Y., Kaya Z, Atilgan ZA, Cil H, et al Association Between Neutrophil to Lymphocyte Ratio and Severity of Coronary Artery Disease. Clin Appl Thromb Hemost 2013 May 7.
6. Turak O, Ozcan F, Isleyen A., Tok D, Sokmen E, Buyukkaya E., et al Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis. Am J Cardiol 2012;110:1405-10.
7. Badesch DB, Abman SH, Simonneau G, Rubin L.J., McLaughlin V V. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest 2007;131:1917-28.
8. Hall S, Brogan P, Haworth S.G., Klein N. Contribution of in-fammation to the pathology of idiopathic pulmonary arterial hypertension in children. Thorax 2009;64:778-83.
9. Bowers R, Cool C, Murphy R.C., Tuder RM, Hopken MW, Flores SC, et al Oxidative stress in severe pulmonary hypertension. Am J Respir Crit Care Med 2004;169:764-9.
10. DeMarco VG, Habibi J, Whaley-Connell AT, Schneider R.I., Heller RL, Bosanquet JP, et al Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat. Am J Physiol Heart Circ Physiol 2008;294:H2659-68.
11. Steiner MK, Syrkina OL, Kolliputi N, Mark E.J., Hales CA, Waxman AB Interleukin-6 overexpression induces pulmonary hypertension. Circ Res 2009;104:236-44.
12. Hotchkiss RS, Karl IE The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-50.
13. Nicolls MR, Taraseviciene-Stewart L, Rai P.R., Badesch DB, Voelkel NF Autoimmunity and pulmonary hypertension: a perspective. Eur Respir J 2005;26:1110-8.
14. Ulrich S, Nicolls MR, Taraseviciene L, Speich R., Voelkel N. Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension. Respiration 2008;75:272-80.
15. Kalay N, Dogdu O, Koc F., Yarlioglues M, Ardic I, Akpek M., et al Hematologic parameters and angiographic progression of coronary atherosclerosis. Angiology 2012;63:213-7.
16. Buyukkaya E, Karakas MF, Karakas E, Akçay AB, Kurt M., Tanboga IH, et al Correlation of Neutrophil to Lymphocyte Ratio With the Presence and Severity of Metabolic Syndrome. Clin Appl Thromb Hemost 2012 Sep 18.
17. Can MM, Tanboǧa IH, Demircan H.C., Ozkan A., Koca F, Keleş N, et al. Enhanced hemostatic indices in patients with pulmonary arterial hypertension: an observational study. Thromb Res 2010;126:280-2.
18. Güvenc T.S., Erer HB, Ilhan S, Zeren G., Ilhan E, Karakuş G, et al. Comparison of mean platelet volume values among different causes of pulmonary hypertension. Cardiol J 2012;19:180-7.
19. Arslan D, Cimen D, Guvenc O., Kaya F, Sert A, Oran B. Platelet distribution width and mean platelet volume in children with pulmonary arterial hypertension secondary to congenital heart disease with left-to-right shunt: new indices of severity? Pediatr Cardiol 2013;34:1013-6.
20. Soon E, Holmes AM, Treacy C.M., Doughty NJ, Southgate L, Machado RD, et al Elevated levels of infammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation 2010;122:920-7.
21. Gul M, Uyarel H, Ergelen M., Karacimen D, Ugur M, Turer A., et al The relationship between red blood cell distribution width and the clinical outcomes in non-ST elevation myocar-dial infarction and unstable angina pectoris: a 3-year follow-up. Coron Artery Dis 2012;23:330-6.
22. Zalawadiya SK, Zmily H, Farah J., Daifallah S, Ali O, Ghali JK Red cell distribution width and mortality in predominantly African-American population with decompensated heart failure. J Card Fail 2011;17:292-8.
23. Ozsu S, Abul Y, Gunaydin S., Orem A, Ozlu T. Prognostic Value of Red Cell Distribution Width in Patients With Pulmonary Embolism. Clin Appl Thromb Hemost 2012 Nov 8.
24. Rhodes CJ, Wharton J, Howard L.S., Gibbs JS, Wilkins MR Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart 2011;97:1054-60.